JP2009512699A5 - - Google Patents

Download PDF

Info

Publication number
JP2009512699A5
JP2009512699A5 JP2008536688A JP2008536688A JP2009512699A5 JP 2009512699 A5 JP2009512699 A5 JP 2009512699A5 JP 2008536688 A JP2008536688 A JP 2008536688A JP 2008536688 A JP2008536688 A JP 2008536688A JP 2009512699 A5 JP2009512699 A5 JP 2009512699A5
Authority
JP
Japan
Prior art keywords
dosage form
oral dosage
concentration
active substance
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008536688A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009512699A (ja
Filing date
Publication date
Priority claimed from US11/257,432 external-priority patent/US20070092559A1/en
Application filed filed Critical
Publication of JP2009512699A publication Critical patent/JP2009512699A/ja
Publication of JP2009512699A5 publication Critical patent/JP2009512699A5/ja
Pending legal-status Critical Current

Links

JP2008536688A 2005-10-24 2006-10-11 遅延放出とその後の持続放出の腸溶性を有する液体剤形 Pending JP2009512699A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/257,432 US20070092559A1 (en) 2005-10-24 2005-10-24 Liquid dosage forms having enteric properties of delayed and then sustained release
PCT/US2006/039761 WO2007050294A2 (en) 2005-10-24 2006-10-11 Liquid dosage forms having enteric properties of delayed and then sustained release

Publications (2)

Publication Number Publication Date
JP2009512699A JP2009512699A (ja) 2009-03-26
JP2009512699A5 true JP2009512699A5 (enExample) 2009-11-26

Family

ID=37744211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008536688A Pending JP2009512699A (ja) 2005-10-24 2006-10-11 遅延放出とその後の持続放出の腸溶性を有する液体剤形

Country Status (5)

Country Link
US (1) US20070092559A1 (enExample)
EP (1) EP1940365A2 (enExample)
JP (1) JP2009512699A (enExample)
CN (1) CN101296690A (enExample)
WO (1) WO2007050294A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
ES2396051T3 (es) * 2006-04-26 2013-02-18 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal
WO2010044842A1 (en) * 2008-10-16 2010-04-22 University Of Tennessee Research Foundation Tamper resistant oral dosage forms containing an embolizing agent
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
GB2477590A (en) * 2010-02-05 2011-08-10 Biocopea Ltd A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate
CN110314152B (zh) * 2018-11-27 2021-03-26 西安圣雪沙药物开发有限公司 一种布洛芬缓释微丸胶囊及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL148500B (nl) * 1967-10-07 1976-02-16 Scherer Gmbh R P Depotgeneesmiddelen in capsulevorm.
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
DE3500103C2 (de) * 1985-01-04 1987-01-22 R.P. Scherer GmbH, 6930 Eberbach Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JPS649932A (en) * 1987-07-01 1989-01-13 Toyo Capsel Kk Soft capsule preparation using newly combined component as the base
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
US5723151A (en) * 1995-11-06 1998-03-03 Eastman Chemical Company Cellulose acetate phthalate enteric coating compositions
DK0869810T3 (da) * 1996-06-19 2005-02-07 Novartis Ag Cyclosporinholdige blöde kapselpræparater
ES2234139T3 (es) * 1997-08-11 2005-06-16 Alza Corporation Forma de dosificacion de un agente activo de liberacion prolongada adaptada para la retencion gastrica.
US6191162B1 (en) * 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US6312713B1 (en) * 1998-06-12 2001-11-06 Bernard Korol Polymer matrices for storage and sustained release of drugs and chemicals
US6139875A (en) * 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs
DE69915346T2 (de) * 1998-12-17 2004-07-22 Alza Corp., Mountain View Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
US6797283B1 (en) * 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
JP4610687B2 (ja) * 1999-11-15 2011-01-12 コニカミノルタホールディングス株式会社 原稿読み取り装置
US20040028744A1 (en) * 2002-06-17 2004-02-12 Sauwaluxana Tongaree Mucoadhesive composition
JP2007505129A (ja) * 2003-09-11 2007-03-08 グリュコン テクノロジーズ グループ エルエルシー （−）−ヒドロキシクエン酸の腸溶性送達物
GB0403808D0 (en) * 2004-02-20 2004-03-24 Bioprogress Technology Ltd Films for use as dosage forms

Similar Documents

Publication Publication Date Title
JP2012153724A5 (enExample)
US11207273B2 (en) Method of making an L-menthol dosage form
CN1404389B (zh) 时控脉冲给药系统
JP3902229B2 (ja) 結腸デリバリー用の、多腸溶ポリマー被覆物を有する医薬投与形態
JP3902228B2 (ja) 結腸デリバリー用の医薬投与形態
JP4172917B2 (ja) 急速に効果を発揮し且つ効果的な血漿薬物濃度が急速に低下する制御放出性製剤
JP2020059755A5 (enExample)
JP2017019858A5 (enExample)
JP4999037B2 (ja) 複数のコーティングを有する医薬剤形
JP2008540419A5 (enExample)
US20120244216A1 (en) Coated pharmaceutical capsule dosage form
JP5592902B2 (ja) 治療薬の徐放性組成物
KR20100014629A (ko) 타크로리무스의 변형제형
JPH04501411A (ja) 結腸選択的到達性を持つ経口医薬用製剤
JP2009512699A (ja) 遅延放出とその後の持続放出の腸溶性を有する液体剤形
EP0381220B1 (en) Water dispersible gemfibrozil compositions
Bansal et al. Delivery Strategies and Clinical Significance of Oral Colon-targeted Drug Delivery Systems
CN102755302B (zh) 一种含安全可靠的增塑剂的延迟释放制剂及其制备方法
CN103417544A (zh) 甲氨叶酸复方制剂及其制备方法和用途
JP5443768B2 (ja) 医薬品球状物
CN104274408A (zh) 一种熔融包衣的速释药物微粒及其制备方法
CA2271560C (en) Pharmaceutical dosage form for colonic delivery
CN100336501C (zh) 醋炎痛缓释性圆粒组成物及制备方法
TWI257312B (en) The composition and method of preparing acemetacin retard pellet and its dosage form
US20140271845A1 (en) Coated substrate compositions